EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Caffeic acid phenethyl ester protects Clostridioides difficile infection by toxin inhibition and microbiota modulation

Yan Guo, Yong Zhang, Guizhen Wang, Hongtao Liu, Jianfeng Wang iD, Xuming Deng, Liuqin He, Jiazhang Qiu iD

eLife · 11.06.2025 · 13

DOI: 10.7554/elife.101757 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, online erschienen am 11.06.2025. Verfasst von Yan Guo und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Educ…. Hauptthemen laut MEDLINE: Caffeic Acids, Phenylethyl Alcohol, Clostridioides difficile, Bacterial Toxins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Natural Science Foundation of Jilin Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clostridioides difficile infection (CDI) is the leading cause of hospital-acquired diarrhea that seriously threatens public health. The disruption of normal gut microbiota by the use of broad-spectrum antimicrobial agents enables C. difficile to proliferate in the colon. The emergence and prevalence of hypervirulent C. difficile strains result in increased morbidity, mortality, and high recurrence rates of CDI, thus creating a pressing need for novel therapeutics. The multi-domain toxins TcdA and TcdB are the primary determinants of CDI pathogenesis, rendering them ideal drug targets in the anti-virulence paradigm. In this study, we identified caffeic acid and its derivatives from natural compounds library as active inhibitors of TcdB via a cell-based high-throughput phenotypic screening. Further mechanistic investigations revealed that caffeic acid phenethyl ester (CAPE) could directly bind to TcdB, thus suppressing InsP 6 -induced autoproteolysis and inhibiting glucosyltransferase activity. CAPE treatment remarkably reduces the pathology of CDI in a murine infection model in terms of alleviated diarrhea symptoms, decreased bacterial colonization, and relieved histopathological lesions. Moreover, CAPE treatment of C. difficile -challenged mice induces a remarkable increase in the diversity and composition of the gut microbiota and alterations of gut metabolites (e.g., adenosine, D-proline, and melatonin), which might partially contribute to the therapeutic outcomes of CAPE against CDI. Our results reveal the potential of CAPE as a therapeutic for the management of CDI, or CAPE might serve as a lead compound for the development of antivirulence drugs targeting TcdB.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Caffeic AcidsPhenylethyl AlcoholClostridioides difficileBacterial ToxinsClostridium InfectionsGastrointestinal MicrobiomeBacterial ProteinsAnimalsMiceHumansDisease Models, Animal

Stichwörter der Autor:innen

Clostridioides difficileTcdBgut microbiotainfectious diseasemicrobiologymouse

Substanzen

Caffeic AcidsPhenylethyl Alcoholcaffeic acid phenethyl esterBacterial ToxinsBacterial ProteinstoxB protein, Clostridium difficile

Autor:innen und Institutionen

  • State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, College of Veterinary Medicine, Jilin University, Center for Pa…
  • Center for Pathogen Biology and Infectious Diseases, State Key Laboratory for Zoonotic Diseases, The First Hospital of Jilin University, Changchun, China.
  • Measurement Biotechnique Research Center, College of Biological and Food Engineering, Jilin Engineering Normal University, Changchun, China.
  • Hunan Provincial Key Laboratory of Animal Intestinal Function and Regulation, Hunan International Joint Laboratory of Animal Intestinal Ecology and Health, Laboratory of Animal Nutrition and Human Health, College of Lif…

ORCID-Profile: Jianfeng Wang, Jiazhang Qiu

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Natural Science Foundation of Jilin Province
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Guo, Y., Zhang, Y., Wang, G., Liu, H., Wang, J., Deng, X., He, L., & Qiu, J. (2025). Caffeic acid phenethyl ester protects Clostridioides difficile infection by toxin inhibition and microbiota modulation. eLife, 13. https://doi.org/10.7554/elife.101757

Vancouver

Guo Y, Zhang Y, Wang G, Liu H, Wang J, Deng X, et al. Caffeic acid phenethyl ester protects Clostridioides difficile infection by toxin inhibition and microbiota modulation. eLife. 2025;13. doi:10.7554/elife.101757

BibTeX
@article{Guo2025,
  author = {Guo, Yan and Zhang, Yong and Wang, Guizhen and Liu, Hongtao and Wang, Jianfeng and Deng, Xuming and He, Liuqin and Qiu, Jiazhang},
  title = {Caffeic acid phenethyl ester protects Clostridioides difficile infection by toxin inhibition and microbiota modulation},
  journal = {eLife},
  year = {2025},
  volume = {13},
  doi = {10.7554/elife.101757}
}
Kostenlos starten →